Layer 1

NPA chair steps aside while wholesaler price hike claims investigated

Nitin Sodha: I'm stepping aside with immediate effect so the NPA isn't distracted
Nitin Sodha: I'm stepping aside with immediate effect so the NPA isn't distracted

Nitin Sodha is stepping aside as chair of the National Pharmacy Association (NPA) while a government watchdog investigates his company’s involvement in drug price hiking.

Mr Sodha will hand over his chairman duties while “allegations of collusion against a company in which he owns shares, Lexon UK, are investigated by the Competition and Markets Authority (CMA)”, the NPA announced this afternoon (June 3).

NPA vice-chair Andrew Lane, owner of the AlChem Pharmacy Group and chair of Gloucestershire local pharmaceutical committee, will pick up the chairman duties “for the time being”, the NPA added.

NPA chief executive Mark Lyonette said: “The allegations against Lexon don’t relate to Nitin’s work at the NPA, yet he has made a decision to stand aside as chair in the best interests of the association and its members.”

Mr Sodha added: “I am stepping aside with immediate effect, so the NPA can remain focused on supporting its members and securing a sustainable future for independent pharmacies, rather than be distracted by continued questions about my position as chair.”

The allegations against Lexon

The government’s competition watchdog alleged last month that Lexon, along with manufacturers Alliance Pharmaceuticals, Focus Pharmaceuticals and Medreich, broke the law by agreeing not to compete in the supply of anti-nausea drug prochlorperazine.

Their alleged agreement not to compete for the supply of prescription-only prochlorperazine 3mg buccal tablets led to prices for the NHS rising 700% over four years, the CMA claimed.

The CMA’s findings are provisional, the watchdog added, and the companies have the opportunity to make representations before it reaches a final decision.

Mr Sodha stressed to C+D last year that he currently has limited involvement with the wholesaler, and attends “maybe four” meetings a year.

4 Comments
Question: 
What do you make of Mr Sodha's decision to step down?

Reeyah H, Community pharmacist

Mr Sodha has done the right thing, and let’s hope Lexon have too. 

Aryan Butt,

I thought Ian Strachan did a good job when he was Chairman. Maybe he should be asked to come back.

Community Pharmacist, Community pharmacist

I thought the Lexon rep was a bit too keen....

Peter Smith, Student

Laughable, who would have thought that this would happen? 

Job of the week

Community Pharmacist - Tier 2 provided
South East England, Oxfordshire
Up to £40k per annum - negotiable